UBS fears slowdown in India, US pharma markets; gives 'Sell' on 4 stocks
As per UBS, the Indian pharma market is slowing down due to a sharp increase in unbranded generics
As per UBS, the Indian pharma market is slowing down due to a sharp increase in unbranded generics